Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Finasteride exposure harms tadpole reproduction and hormone balance.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

More research is needed to understand how testosterone is maintained in adult males.

Vitamin D is important for bones, hair, blood pressure, and breast development.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.